The LUNA Fluorescence Angiography System provides the ability to perform and manage serial images over the course of patient treatment. Combined with the SPY-QCM toolkit software, LUNA allows physicians to monitor and objectively analyze the benefits of advanced treatments such as HBOT, skin substitutes and NPWT throughout the episode of care.
Dermacell AWM Human Acellular Dermal Matrix provides a cost-effective, one-application treatment solution for patients with chronic lower extremity ulcerations. In fact, in the largest and most rigorous randomized, controlled trial (RCT) to date using human ADM for chronic wounds, Dermacell AWM demonstrated superior rates of healing and wound closure in Diabetic Foot Ulcers compared to conventional care.1
- Walters J, Cazzell S, Pham H, Vayser D, Reyzelman A. Healing Rates in a Multicenter Assessment of a Sterile, Room Temperature, Acellular Dermal Matrix Versus Conventional Care Wound Management and an Active Comparator in the Treatment of Full-Thickness Diabetic Foot Ulcers. ePlasty. Published online February 2016.
Product Categories
Ostomy Care
Wound Care